<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15459-bib-0017">
 <mixed-citation publication-type="journal" id="bjh15459-cit-0017">
  <string-name>
   <surname>Morgan</surname>, 
   <given-names>G.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Davies</surname>, 
   <given-names>F.E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gregory</surname>, 
   <given-names>W.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Bell</surname>, 
   <given-names>S.E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Szubert</surname>, 
   <given-names>A.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cook</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Drayson</surname>, 
   <given-names>M.T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Owen</surname>, 
   <given-names>R.G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ross</surname>, 
   <given-names>F.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jackson</surname>, 
   <given-names>G.H.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Child</surname>, 
   <given-names>J.A.</given-names>
  </string-name> (
  <year>2013</year>) 
  <article-title>Long‐term follow‐up of MRC Myeloma IX trial: survival outcomes with bisphosphonate and thalidomide treatment</article-title>. 
  <source xml:lang="en">Clinical Cancer Research</source>, 
  <volume>19</volume>, 
  <fpage>6030</fpage>–
  <lpage>6038</lpage>.
  <pub-id pub-id-type="pmid">23995858</pub-id>
 </mixed-citation>
</ref>
